Correct option is C
Sol: The correct answer is (c) GlaxoSmithKline (GSK)
Key Points:
- The world's first malaria vaccine developed for the World Health Organization (WHO) is the RTS,S/AS01(RTS,S) vaccine.
- This vaccine was created through a collaboration between GlaxoSmithKline (GSK) and the PATH Malaria Vaccine Initiative, with significant support from the Bill & Melinda Gates Foundation and various African research centers.
- The RTS,S vaccine received WHO recommendation for widespread use on October 6, 2021, specifically targeting children in regions with moderate to high transmission of Plasmodium falciparum malaria
Information booster:
- Second malaria vaccine, R21/Matrix-M, has also been developed by the University of Oxford in partnership with the Serum Institute of India. This vaccine has shown promising efficacy and has been licensed for use in several African countries However, RTS,S remains the first malaria vaccine to be endorsed for broad use by WHO